A Phase II Study of AK112 (PD-1/VEGF Bispecific) in Combination with Chemotherapy for Patients with Advanced Non-squamas Non-mall Cell Lung Cancer and Malignant Pleural Effusion
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Ivonescimab (Primary) ; Carboplatin; Cisplatin; Paclitaxel; Pemetrexed
- Indications Malignant pleural effusion; Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Jan 2025 New trial record